You can buy or sell VRCA and other stocks, options, ETFs, and crypto commission-free!
Verrica Pharmaceuticals, Inc. operates as a clinical-stage medical dermatology company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its lead product VP-102, is a proprietary topical therapy used in common skin indications including Molluscum contagiosum and Verruca Vulgaris. Read More The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
West Chester, Pennsylvania
52 Week High
52 Week Low
Yahoo FinanceMay 1
Verrica Pharmaceuticals Announces Participation in Upcoming Investor Conferences
WEST CHESTER, Pa., May 01, 2019 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (VRCA), a medical dermatology company committed to the development and commercialization of novel treatments that provide meaningful benefit for people living with skin diseases, today announced that Ted White, Verrica President and CEO, will present a business overview of the company’s pipeline programs at the Bank of America Merrill Lynch 2019 Healthcare Conference in Las Vegas, NV on Tuesday, May 14, 2019 at 2:35...
Expected Aug 6, After Hours